Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $447.19 | 9 | 93.3% |
| Education | $32.27 | 1 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $225.31 | 2 | $0 (2018) |
| Biohaven Pharmaceutical Holding Company Ltd. | $125.00 | 1 | $0 (2022) |
| ABBVIE INC. | $96.88 | 6 | $0 (2024) |
| Novo Nordisk Inc | $32.27 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.77 | 2 | Novo Nordisk Inc ($32.27) |
| 2022 | $125.00 | 1 | Biohaven Pharmaceutical Holding Company Ltd. ($125.00) |
| 2021 | $82.38 | 5 | AbbVie Inc. ($82.38) |
| 2018 | $225.31 | 2 | Amgen Inc. ($225.31) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 05/19/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PRIMARY CARE | ||||||
| 12/06/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 09/05/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $100.31 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 141 | 287 | $67,564 | $20,918 |
| 2022 | 6 | 165 | 258 | $57,982 | $19,781 |
| 2021 | 5 | 175 | 318 | $73,668 | $24,735 |
| 2020 | 6 | 193 | 347 | $78,421 | $21,773 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 193 | $53,492 | $16,000 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 60 | $11,394 | $3,279 | 28.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,500 | $1,079 | 71.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $1,178 | $561.26 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 146 | $39,274 | $11,845 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 15 | $5,400 | $2,067 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 39 | $7,215 | $1,880 | 26.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $2,475 | $1,776 | 71.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $2,068 | $1,508 | 72.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $1,550 | $705.00 | 45.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 198 | $51,814 | $17,098 | 33.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 32 | $11,168 | $3,551 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 40 | $7,160 | $2,225 | 31.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 22 | 22 | $1,914 | $1,436 | 75.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 26 | 26 | $1,612 | $425.36 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 65 | 192 | $50,108 | $13,327 | 26.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 37 | 39 | $13,556 | $3,492 | 25.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 61 | $10,907 | $3,157 | 28.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 20 | 20 | $1,680 | $1,220 | 72.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 22 | 22 | $1,364 | $363.44 | 26.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 13 | 13 | $806.00 | $213.77 | 26.5% |
About Dr. Heidi Thomas, MD
Dr. Heidi Thomas, MD is a Internal Medicine healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356342091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heidi Thomas, MD has received a total of $479.46 in payments from pharmaceutical and medical device companies, with $46.77 received in 2024. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($447.19).
As a Medicare-enrolled provider, Thomas has provided services to 674 Medicare beneficiaries, totaling 1,210 services with total Medicare billing of $87,208. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Salem, OR
- Active Since 08/03/2005
- Last Updated 06/16/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1356342091
Products in Payments
- NURTEC ODT (Drug) $125.00
- Prolia (Biological) $125.00
- Aimovig (Biological) $100.31
- UBRELVY (Drug) $47.60
- QULIPTA (Drug) $34.78
- Wegovy (Drug) $32.27
- VRAYLAR (Drug) $14.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salem
Dr. Michael Katcher, Md, MD
Internal Medicine — Payments: $124,347
Jonh Pineda-Bonilla, Md, MD
Internal Medicine — Payments: $51,042
Dr. Garry Miller, D.o, D.O
Internal Medicine — Payments: $17,070
David Bennion, Md, MD
Internal Medicine — Payments: $13,939
Mr. Gautam Jha, Md, MD
Internal Medicine — Payments: $11,191
Dr. Troy Lunceford, Md, MD
Internal Medicine — Payments: $10,868